Columbia U - Herbert Irving Comprehensive Cancer Center — New York, New York

Columbia U - Herbert Irving Comprehensive Cancer Center is a clinical research site located in New York, New York, United States 10032.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Columbia U - Herbert Irving Comprehensive Cancer Center has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Relapsed/Refractory Follicular Lymphoma, Follicular Lymphoma, Refractory Follicular Lymphoma.

Sponsors: Epizyme, Inc..

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Columbia U - Herbert Irving Comprehensive Cancer Center?

Columbia U - Herbert Irving Comprehensive Cancer Center has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Columbia U - Herbert Irving Comprehensive Cancer Center conducted?

Columbia U - Herbert Irving Comprehensive Cancer Center has 1 clinical trials on record, with 1 currently active. Their work covers Relapsed/Refractory Follicular Lymphoma, Follicular Lymphoma, Refractory Follicular Lymphoma.

Is Columbia U - Herbert Irving Comprehensive Cancer Center accredited by Crixeo Health?

Columbia U - Herbert Irving Comprehensive Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Columbia U - Herbert Irving Comprehensive Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.